Skip to main content
F1000Research logoLink to F1000Research
. 2023 Jan 9;12:33. [Version 1] doi: 10.12688/f1000research.127377.1

Dance/movement therapy as a holistic approach to diminish health discrepancies and promote wellness for people with schizophrenia: a review of the literature

Jacelyn Biondo 1,a
PMCID: PMC10429376  PMID: 37593363

Abstract

Individuals with a diagnosis of schizophrenia face a myriad of obstacles to wellness, beginning with diagnostic discrepancies including over- and misdiagnoses on the schizophrenia spectrum. People with schizophrenia experience profound amounts of stigmatization from the general population, their healthcare providers, and even themselves. Such stigmatization creates a barrier for wellness, poorer prognoses, and often limits adherence to physical and mental healthcare. Moreover, it can exacerbate the already stifling symptomatology of their diagnoses, including specific bodily-related symptomatology. Oftentimes, a diagnosis of schizophrenia disrupts one’s relationship with their body including a diminished mind-body connection, decreased interoceptive awareness, and thus unsuccessful intra- and interpersonal relationships. Some recent research suggests the use of mind-body therapies, however, if these practices are internalizing, they may not be appropriate for people with schizophrenia experiencing more acute symptomatology excluding them from treatment. Dance/movement therapy (DMT) is an embodied psychotherapeutic treatment option that can support participants in improving mind-body connection, social relationships, and self-regulatory skill development. Research on DMT has shown promising results for people with schizophrenia, however such research is limited and would benefit from increased studies that particularly measure the effects of DMT on mind-body connection and increased interoception for people with schizophrenia. Moreover, integrative and collaborative treatment models that couple DMT and biofeedback may further our understanding of the physiological and neurological effects of DMT interventions for people with schizophrenia and beyond. This review will examine the recent literature on health inequities for people with schizophrenia, their specific body-based disruptions and needs, and DMT as a promising treatment model, particularly when coupled with biofeedback.

Keywords: dance/movement therapy, schizophrenia, mind-body connection, interoception, healthcare disparities, embodiment, neurobiology

Introduction

Individuals diagnosed with schizophrenia face discrepancies regarding health care services at a rate much higher than the general population ( Moore et al., 2015; Oud & Jong, 2017; Tan et al., 2021). The inequities they face include both physical ( Moore et al., 2015; Sølvhøj et al., 2021) and mental health care ( Ivanova, 2021; Metzl & Roberts, 2014; Rössler, 2016), and contribute to a decrease in general wellbeing and thus quality of life. People with schizophrenia have specific and additional needs due to their complicated symptomatology inclusive of body-based dysregulations ( Biondo et al., 2021; Davis, 2019; Klaver & Dijkerman, 2016). Dance/movement therapists have foundational knowledge rooted in embodied, trauma-informed, nonverbal psychotherapeutic practices ( Homann, 2020; Koch, 2017). Through a strengths- and body-based approach, dance/movement therapy (DMT) surpasses traditional verbal communication, establishing inclusion for many forms of preferred communication styles ( Biondo et al., 2021). Joining through movement facilitates increased attunement, which is a necessary component to foster self-regulation and encourage healthy interpersonal skills. Additionally, DMT provides the framework to access embodiment and neurophysiological theories, which supports the multifaceted needs of individuals diagnosed with schizophrenia. One of the primary tenets of DMT is that the mind and body are interrelated and thus have a relationship that inform wellness. DMT is an active and embodied treatment option to increase mind-body connection. This paper will review the current literature on physical and mental health care inequities for people with schizophrenia, bodily disturbances associated with the diagnosis, and ways in which DMT, possibly coupled with biofeedback, can be a holistic approach to treatment.

Discussion

Mental health disparities

Mental health disparities for people begin with diagnostics. This is largely due to the structural racism that occurs within mental health facilities. Systemically racist underpinnings of mental health care facilities cause undue stress for People of Color (POC), particularly Black and African American men ( Metzl & Roberts, 2014). Pre-Civil Rights era, a diagnosis of schizophrenia was largely associated with middle-class, white housewives experiencing symptoms of regressive behaviors, disrupted moods, and an inability to care for the home ( Metzl & Roberts, 2014). However, Metzl and Roberts (2014) noted that this shifted dramatically in the mid-1950s in parallel with the Civil Rights movement. At that point in time, schizophrenia became a diagnosis largely relegated to Black and African American men at rates of 65% more frequently than white men. By the 1970s and 1980s, Black and African American men were five to seven times more likely to receive a diagnosis of paranoid schizophrenia than their white male counterparts ( Metzl & Roberts, 2014). The authors asserted that both historically and presently, Black men are more likely to receive a diagnosis of schizophrenia than white men with the same presenting symptoms. This research identified an over–diagnosis of schizophrenia and an under–diagnosis of mood disorders for Black and African American men. This is partially attributed to the mistrust and stigmatization psychiatrists and other mental health care workers have towards POC and people with severe mental illnesses ( Metzl & Roberts, 2014).

Individuals with schizophrenia experience stigmatization at rates higher than other individuals with mental health diagnoses ( Rössler, 2016). Ivanova (2021) defined stigmatization as “a mark of shame, disgrace or disapproval which results in an individual being rejected, discriminated against, and excluded from participating in a number of different areas of society” (p. 47). Historically, people who experienced mental illness were treated extremely poorly with consequences of being held against their will, tortured, or even killed ( Rössler, 2016). Although these practices have ceased, the fear of people with mental illness, particularly those with a diagnosis of schizophrenia, remains. The association of violence or aggression with individuals with schizophrenia is incorrect ( Ivanova, 2021; Rössler, 2016). Research shows that people with schizophrenia are 75-120% more likely to be a victim of violence than the general population ( Ivanova, 2021).

Stigmatization also affects people with schizophrenia on personal and social levels. In a survey inclusive of 27 countries, people with schizophrenia reported discriminatory behaviors in their personal relationships at a rate of 50% and in job related relationships at a rate of 67% ( Rössler, 2016). This stigmatization traverses into the relationship between people with schizophrenia and their health care providers, who have a higher rate of negative beliefs about people with schizophrenia than the general population ( Rössler, 2016). Stigmatizating behaviors extend to psychiatrists, making them less likely to meet in a clinical context with individuals diagnosed with schizophrenia ( Rössler, 2016). Consistent stigmatizing behaviors from others can lead to self–stigmatization behaviors for individuals with schizophrenia —compounding a diminished sense of self-esteem and self–efficacy ( Rössler, 2016). This ultimately inhibits and limits the care that people with schizophrenia are seeking and receiving, and contributes to negative effects on their overall prognosis ( Ivanova, 2021).

In events where people with schizophrenia have sought mental health services, some reported feeling “devalued, dismissed, and dehumanized by healthcare professionals” ( Ivanova, 2021, p. 49). This speaks to the level of exclusion people with schizophrenia experience, deeply rooted in stigmatization ( Lincoln et al., 2021). Individuals with schizophrenia are often excluded from medical decision making and feel coerced by medical care practitioners ( Ivanova, 2021). Both medical decision making and social exclusion can have detrimental effects on mental and physical wellness, leading to an increase in symptomatology ( Lincoln et al., 2021). Research has shown a direct relationship between feelings of social exclusion with negative neurobiological responses ( Lincoln et al., 2021; Metzl & Roberts, 2014). Beyond medical care, researchers have often excluded individuals with schizophrenia from their studies due to the presence of positive symptomatology or an exacerbation of symptomatology indicating they may be unable to manage the intervention or treatment ( Biondo et al., 2021). This prevents people with schizophrenia from informing, testing, and responding to possible treatment protocols that could provide them with more effective care. A less medical and more psychosocial approach to support could mediate some of this stigmatization, and resultant exclusion, exhibited by health care providers ( Ivanova, 2021). Unfortunately, these undesirable behaviors of medical professionals traverse beyond mental health care and into the realm of physical health care as well ( Kohn et al., 2022; Oud & Jong, 2017; Sølvhøj et al., 2021; Swildens et al., 2016).

Physical health disparities

People with a diagnosis of schizophrenia have a lifespan 10-20 years shorter than the general population and have a 2.5 times higher risk of death compared to the general population ( Moore et al., 2015; Oud & Jong, 2017). The co-morbidity rate for schizophrenia and somatic disorders—including diabetes mellitus, cardiovascular diseases, and respiratory diseases—is the highest level of physical health co-morbidity as compared to other people diagnosed with severe mental illness ( Tan et al., 2021). There are many factors that contribute to inequities in health care for people with schizophrenia, including disparities in access, use, and provision of services ( Kohn et al., 2022) and general limited use of somatic health care practitioners ( Swildens et al., 2016). In addition to the poor medical treatment adherence rate ( Kohn et al., 2022; Laursen, 2019), people with schizophrenia also received poorer care, less preventative and curative screening processes, and less prescriptions ( Laursen, 2019). Somatic diseases are often underdiagnosed and under-treated amongst people with severe mental illness, particularly schizophrenia ( Kohn et al., 2022; Laursen, 2019; Oud & Jong, 2017).

One of the causes of poorer quality of care is the ongoing stigmatization of people with schizophrenia ( Kohn et al., 2022; Oud & Jong, 2017; Sølvhøj et al., 2021; Swildens et al., 2016). Individuals diagnosed with schizophrenia feel that they are spoken down to or even patronized by doctors when they are seeking treatment. Furthermore, due to differences in communication styles and preferences, people with schizophrenia have reported feeling uncomfortable expressing their concerns to doctors for fear of being physically or emotionally hurt or becoming recipients of other forms of stigmatization ( Kohn et al., 2022).

Stigmatizing behaviors compound communication difficulties, reducing the ability for people with schizophrenia to express their physical concerns readily ( Kohn et al., 2022). This surge in stress may also result in the emergence of or contribution to somatic diseases ( Oud & Jong, 2017; Vancampfort et al., 2017). Oftentimes, such communication difficulties heighten isolative behaviors. Negative symptomatology of schizophrenia, including social withdrawal and lack of spontaneity, can interfere with appropriate physical health care. These symptoms encourage a sedentary lifestyle, which typically decreases one’s ability to report physical health symptoms accurately and readily ( Moore et al., 2015; Oud & Jong, 2017; Vancampfort et al., 2017). Moreover, a sedentary lifestyle coupled with metabolic effects of antipsychotic medications contribute to people with schizophrenia being overweight, furthering their propensity towards developing a somatic disease ( Laursen, 2019; Moore et al., 2015; Oud & Jong, 2017). Both the negative symptomatology and the negative side effects of antipsychotics trigger poor self-esteem ( Vancampfort et al., 2017) and a loss of hope for people with schizophrenia ( Oud & Jong, 2017). The added complication of having a limited social support in addition to the aforementioned complications all act as barriers to accessible, quality health care of people with schizophrenia ( Vancampfort et al., 2017).

Body symptomatology

People with schizophrenia often have specific care needs due to movement dysregulations that are associated with their diagnosis ( Biondo et al., 2021; Davis, 2019). The Diagnostic and Statistical Manual of Mental Disorders, Fifth edition (DSM-5) notes macro-level movement dysregulations such as holding bizarre postures or grossly disorganized movements ( American Psychological Association [APA], 2013); however, there are many more subtle and disruptive bodily disturbances associated with schizophrenia including movement fragmentation, unsynchronized movement, subtle and bizarre facial expressions, or limited ability for spontaneous movements or gestures ( Biondo et al., 2021; Davis, 2019).

Bodily disturbances and diminished mind-body connection

Diminished body awareness often correlates with higher symptomatology, which thus contributes to further bodily disruptions ( Costantini et al., 2020). This cycle of symptomatology and body disturbances disallows healthy mind-body connectivity for people with schizophrenia. Typically, bodies and brains communicate with one another in order to maintain a homeostatic relationship within one’s self. This reciprocal communication pathway allows for self-regulatory actions as needed ( Yao & Thakkar, 2022). These and other body disruptions for people with schizophrenia contribute to a significant decrease in mind-body connection, which interfere with wellness on multiple levels.

Individuals diagnosed with schizophrenia may experience difficulty with interpreting their own body signals as well as those of others ( Oud & Jong, 2017). This also attributes to the disruption of body boundaries ( Benson et al., 2019; Costantini et al., 2020); at times they do not understand where their bodies end and others begin. A diminished sense of boundaries can have both intra– ( Ardizzi et al., 2016; Benson et al., 2019; Costantini et al., 2020; Torregrossa et al., 2022) and inter–personal ( Torregrossa et al., 2022) difficulties. On an intrapersonal level, individuals may experience a disruption of their body in shape, size, location, ownership ( Costantini et al., 2020), and pain levels ( Kohn et al., 2022; Yao & Thakkar, 2022) — they may even have difficulty recognizing their own voice or face ( Benson et al., 2019). Moreover, without a grounded sense of bodily self, people with schizophrenia often experience a diminished ego or sense of self ( Benson et al., 2019; Biondo et al., 2021; Costantini et al., 2020; Torregrossa et al., 2022; Yao & Thakkar, 2022).

Interoception

Further compounding a limited sense of self for people with schizophrenia is their often disrupted interoceptive awareness. Healthy interoceptive awareness is associated with brain functioning and can be affected by a diagnosis of schizophrenia. Interoception is the internal and physiological awareness of one’s bodily sensations ( Ardizzi et al., 2016; Torregrossa et al., 2022; Yao & Thakkar, 2022), that supports an integrative processes of internal body cues ( Yao & Thakkar, 2022). Thus, without interoceptive awareness, people with schizophrenia often experience increased positive symptomatology ( Torregrossa et al., 2022). Inhibited interoception alters one’s ability to appropriately regulate the autonomic nervous system, which is essential to survival. It similarly affects the response rate of receiving external sensory signals—exteroception—and the ability to process cognition and emotion ( Ardizzi et al., 2016; Yao & Thakkar, 2022). Ardizzi et al. (2016) noted that “interoceptive accuracy … also appears to be involved in the autonomic regulation during social interactions and individual resilience ability,” (p. 2) further compounding interpersonal relationships.

In order to fully understand and relieve symptomatology of the body for people with schizophrenia, it is argued we need to use the body as a tool for exploration and healing ( Klaver & Dijkerman, 2016). Yao and Thakkar (2022) noted that “exploring how persons with schizophrenia experience their bodies and interpret their bodily signals is potentially key to understanding illness mechanisms” (p. 758).

Mind-body treatments

Mind-body treatment interventions have proven effective for people with schizophrenia; however, one caveat to inclusion into these practices is stabilization of acute symptomatology of schizophrenia. Therefore, mind-body connection interventions for people with schizophrenia often focus on the diminishment of negative symptomatology ( Behere et al., 2019; Sabe et al., 2019; Vogel et al., 2019). This is due, in part, to the internalization that accompanies some of the more meditative practices of mind-body connectivity, which may increase positive symptomatology. In their review, Behere et al. (2019) suggested that yoga may be effective in improving negative symptomatology, however, there was no mention of whether the interventions had an effect on mind-body connectivity. In their systematic review ( K = 15; N = 1081), Sabe et al. (2019) noted that that mind-body therapies, such as tai chi, yoga, and qigong, support increased self-efficacy and agency, and decrease stress for people experiencing negative symptoms of schizophrenia.

Vogel et al. (2019) reviewed mind-body and aerobic exercises in their meta–analysis ( K = 22; N = 1249), noting that typically psychopharmacological and some psychological interventions are ineffective at treating negative symptomatology of schizophrenia. They further posited that physical exercise can have beneficial effects on neural pathways as these neural pathways relate to the internal reward system. Moreover, physical exercise was shown to be effective at decreasing negative symptoms and feelings of depression, while increasing working memory, social cognition, attention, cardiorespiratory fitness, and improving Positive and Negative Symptom Scale (a medical scale used for measuring symptom severity of patients with schizophrenia) scores ( Vogel et al., 2019). The authors concluded that activation is an important component of wellness for people with schizophrenia and that mind-body exercise shows promise as an intervention for this population.

Dance/movement therapy

Dance/movement therapy (DMT), rooted in nonverbal communication and dance as a healing factor, is an under-researched approach to increasing mind-body connectivity. Dance/movement therapy is defined by the American Dance Therapy Association (2016) as “the psychotherapeutic use of movement to promote emotional, social, cognitive, and physical integration of the individual for the purpose of improving health and well-being” ( https://www.adta.org). Koch et al. (2019) conducted a meta-analysis which indicated that DMT has proven to be an effective psychosocial treatment option for a number of psychological and health related outcomes.

Recent research

The effects of DMT on symptom management for people with schizophrenia has shown promising results for people with both acute ( Biondo et al., 2021) and chronic ( Bryl et al., 2020) presentations of the diagnosis. Recent research has shown DMT to be effective in reducing positive ( Biondo et al., 2021) and negative symptoms of schizophrenia ( Biondo et al., 2021; Bryl et al., 2020; Gökcen et al., 2020; Savill et al., 2017). Of particular interest for this review are the following additional results yielded from the research studies: increased social connectivity ( Biondo et al., 2021; Bryl et al., 2020; Gökcen et al., 2020); mind-body awareness, and self-awareness ( Biondo et al., 2021; Bryl et al., 2020).

In our previous work, we examined the effects of a single-session DMT intervention for people with schizophrenia who were currently in an inpatient psychiatric facility due to symptom exacerbation ( Biondo et al., 2021). This mixed methods feasibility study ( N = 28) showed promising results in the diminishment of psychological discomfort and positive and negative symptoms of schizophrenia, as measured by the Brief Psychiatric Rating Scale, for participants randomized to a DMT intervention versus those in a treatment as usual control group. The qualitative findings substantiated the quantitative findings and provided complementary data in which participants reported increased interpersonal skills and feeling a sense of belonging. This is particularly pertinent based on the aforementioned stigmatization people with schizophrenia are faced with, contributing to disrupted interpersonal relationships. Both Biondo et al. (2021) and Bryl et al. (2020) reported an increase in self-awareness inclusive of mind-body awareness in these studies.

Bryl et al. (2020) conducted a mixed methods randomized controlled trial ( N = 31) providing 20 group DMT sessions over 10 weeks. Although the quantitative results of this study did not show significant findings, the qualitative data provided rich accounts of participant experiences in the DMT sessions. Participants articulated a greater awareness of self-integration including an increase in mind-body connectivity, and an increase in awareness of body boundaries ( Bryl et al., 2020). A similar theme was noted in our 2021 research, as participants shared feelings of increased self-awareness, particularly as it related to a positive change in their symptomatology. Increased self-awareness often led to reports of an increase in self-confidence and self-efficacy ( Biondo et al., 2021; Bryl et al., 2020).

Following their respective study interventions, participants expressed an increase in motivation to engage in more activities ( Bryl et al., 2020) and further treatment ( Biondo et al., 2021). A desire to continue activation may have been inspired by increased insight around felt changes from the sessions ( Biondo et al., 2021), and a connection participants made between physical and mental health ( Bryl et al., 2020).

Contributing factors

Tenets of the embodied aesthetics framework ( Koch, 2017), affective and embodied neurobiology ( Homann, 2010, 2020), and the embodied–enactive–interactive brain ( Vaisvaser, 2021) underlie the foundations of DMT that may support wellness for people with schizophrenia. For many years of practice in the creative arts therapies—dance/movement, music, and art therapy—there have been notable gaps in theoretical frameworks that explained the active factors that contributed to wellness ( Koch, 2017). In response to this, Koch (2017) focused her research on developing the embodied aesthetics framework in which “the body is seen as a living organism (organismic metaphor), a unity with multiple interfaces to the environment and other persons, constituting emergent superordinate units beyond the person” (p. 86).

Embodied aesthetics

The embodied aesthetics framework situates and overlaps the following components: bodily consciousness; environmental interactions, and an active body as a center for knowledge. Rooted in this theory, Koch (2017) identified five groupings of identified active factors that contribute to wellness: (1) hedonism; (2) aesthetics; (3) (nonverbal) meaning making; (4) enactive transitional support; and (5) generativity. Within each of these active factors, further detail is provided to encapsulate the contributors to wellness more fully.

Improvisation and playfulness are highlighted as significant components of hedonism, lending to creativity, strength, self-efficacy, and interpersonal connectivity. The role of aesthetics is not only to produce beauty, but also to feel confident that one creates beauty. Authenticity of movement provides self-efficacy for the mover, while allowing someone to truly be seen and fostering mind-body connection. Such nonverbal communication is a premise of DMT. In Koch’s (2017) framework, this can be sectioned into cognitive, affective, and transpersonal symbolizing. In the former, participants of DMT are able to cognitively organize and integrate symbols that emerged from the dance. In affective symbolizing, the dance becomes a vehicle for processing and expressing emotions. In the latter, the dance becomes a spiritual bridge connecting the mover to the understanding of universal cohesion and a place for ritual to form. Through these processes, the movement creates and maintains containment for the participant(s) providing safety in expression and a trajectory towards wellness. With this enactive transitional support, movers can develop agency, re-establish self-safety, and encourage activation. The final category of generativity serves the mover in being a creator, which fosters self-efficacy, agency, continued activation, and resilience ( Koch, 2017). Together, the components of the embodied aesthetics provide support for increased mind-body connection and physical and mental wellness.

Embodied neurobiology

The experiential nature of DMT lends towards an embodied neurological approach that connects the mind and body through movement experiences and nonverbal psychological processing. The collaborative creation of in-the-moment intervention choices made between participant and therapist allow agency and therapeutic rapport to be at the forefront of DMT sessions. Homann (2020) theorized five components to the embodied neurological approach to DMT: (1) polyvagal and biochemical regulation; (2) interoception; (3) empathy and attunement; (4) memory and affective systems and (5) brain lateralization. Priority is placed on the mind-body connection as a contributing factor to accessing one’s emotional intelligence and defining a healthy sense of self. Furthermore, Homann (2020) found:

DMT’s unique emphasis on experiential engagement of the body has significant therapeutic implications, engaging the mind from the inside out. Movement engages deep systems of biochemical regulation, facilitates arousal and rest, and stimulates the core of self–perception at the neurological intersections of emotional, sensory, and cognitive processes. (p. 298)

Dance/movement therapy informed by Polyvagal theory promotes the simultaneity of activation and rest and is often fostered by safe social engagement. Such safety is developed through attunement and can be experienced through touch and gaze ( Homann, 2010). Gray (2017) referred to the “safety–trust–relationship continuum” in her framework for Polyvagal–informed DMT as a foundational component to shifting physiological, and thus psychological states in the therapeutic process (p. 44). Early ruptures in attachment can manifest though affective, cognitive, and physical reactions. With this in mind, it is imperative that the repair processes access each of those manifestations, which is possible through DMT ( Gray, 2017; Homann, 2020). Through the DMT process, participants develop an increase in body awareness while cultivating feelings of relaxation, self-regulation, and agency. Moreover, as individuals receiving treatment create a space of relative safety, they are provided with greater access to a healthy relationship with their body. The therapeutic process of dance and movement within a DMT session can improve interoception, thus providing functional access to body and neurological activation, resulting in greater understanding of physical and emotional needs ( Homann, 2020).

This process of developing greater awareness of self can then transfer to fostering healthier and more productive interpersonal relationships. Attachment is developed through empathic connections, and nonverbal communication is a pathway through which mirror neurons are activated ( Homann, 2010). Kinesthetic attunement or embodied empathy is experienced when a dance/movement therapist and client engage in mirroring one another’s movements, a common technique of DMT. Imparting a sense of being seen in this way for people with schizophrenia validates their authentic selves and instills a sense of pride and feelings of belonging ( Biondo et al., 2021).

A relationship substantiated by attunement, empathy, and authenticity allows for depth of processing through nonverbal experiences including intersubjectivity and integration of implicit and explicit memory. The nonverbal attunement and neuronal matching experienced collectively by dance/movement therapists and clients creates safety and the capacity for sharing unconscious material through intersubjective processes ( Homann, 2010). This intersubjective experience “activates the mirror neuron system, and, through consequential neuronal, hormonal, and chemical cascades connecting the limbic system, the autonomous nervous system and the right hemisphere’s orbitofrontal cortex, facilitates the experience of being with another, in a conscious manner” ( Homann, 2010, p. 90). This integrative process happens on emotional, sensorial, and cognitive levels.

Integration expands to that of memory as implicit memory can be stored in the body and elicited through the embodied processes of DMT and become explicit. This process not only allows recollection of memory, but it also provides an environment for emotional processing and re–narration to create a place of safety for deeper exploration and healing ( Homann, 2020). Furthermore, integration goes beyond that of implicit and explicit memory and extends to lateralization of the brain. Movements, particularly those which crosses the midline and engage the whole body, support an integration of brain hemispheres providing lateralization, whole brain connectivity, and thus integration of self ( Homann, 2020).

Embodied–enactive–interactive Brain

The embodied–enactive–interactive brain framework is an integrative approach of the creative arts therapies with fundamentals of neuroscience that takes similar approaches to the two aforementioned frameworks. Vaisvaser (2021) theorized that the mind, body, and environment intersect which creates a space for integration and thus wellness. Furthermore, exploration of brain functions as they relate to therapeutic factors are presented in five sections: (1) embodiment through a neuroscientific lens; (2) “predictive nature of the mind and the formation and reformation of internal models”; (3) “predictive processing mechanisms in the context of psychic apparatus”; (4) “developmental and therapeutic implications of the brain’s predictive mechanisms”; and (5) “the relational account of neural functioning and the underpinnings of empathy” ( Vaisvaser, 2021, p. 2). Underlying the embodied–enactive–interactive brain is the premise that mind, body, and interpersonal relationships are the root of healing processes for which the creative arts therapies are a vehicle.

The concept of an embodied brain suggests that the body—and particularly interoceptive and proprioceptive awareness—plays an active role in cognitive processes. Sensory experiences of the body are not only a receptive vessel for informational absorption, but also activators for neural indicators of sensory, motor, emotional, and linguistic information ( Vaisvaser, 2021). The environmental component of this framework aligns with social engagement in Polyvagal theory, placing value on the relational component of cognitive and emotional processes. With that, the intersectionality of our mind–body–relational being provides a platform for perception of self and other through creative processing. The predictive brain has a complex and multisensory relationship with the body and environment. Brain prediction, or the “embodied brain,” in which the brain reflects on past experiences in order to determine probable outcomes, incorporates interoceptive knowledge to predict movement, intention, and emotion, and to further agency, self–efficacy, and self–awareness ( Vaisvaser, 2021).

Vaisvaser (2021) theorized that an embodied or predictive brain encourages and supports advancement or progress within the therapeutic realm. Therefore, individuals engaged in the creative arts therapies connect with interoceptive and exteroceptive sensory information, which, through processing, increases emotional awareness and expression. Per Vaisvaser (2021) this then contributes to activation, disrupting the potential for returning to a homeostatic place of stagnancy. The creative arts therapies provide a structure for positive disruption of that which is familiar and lead to the creation of new opportunities. Dance/movement therapy can thus be an opportunity for emotional expressivity, externalization, and therapeutic meaning–making ( Biondo et al., 2021; Vaisvaser, 2021). Furthermore, re–narration of past traumatic events can provide an opportunity for integration and insight. This forward movement is further cultivated by a safe environment and therapeutic rapport ( Vaisvaser, 2021).

Vaisvaser’s (2021) review suggests that these introspective and intrapsychic experiences are deepened through relational encounters both overt and intersubjective. Neurologically, our brains are wired to seek out social engagement. Verbal and nonverbal interactions are instrumental in healthy and adaptive brain functioning though activation of mirror neurons and neuronal synchronization ( Vaisvaser, 2021). These processes aide in an increase in intra– and interpersonal emotional awareness, as well as the release of oxytocin, supportive of adaptive attunement. Empathy, kinesthetic and otherwise, creates pathways for intersubjective processes and mentalization. “Importantly, mentalization during empathic engagement refers to the attribution of emotions, wishes, desires, and needs … suggesting that distinct neural networks are involved in self–knowing and knowing others…” ( Vaisvaser, 2021, p. 6–7). Moreover, shared moments of synchrony through kinesthetic empathy establish foundational tools for rapport building, co–regulation, healthy attachment, and resilience, particularly when rooted in arts and artistic experiences. Vaisvaser (2021) suggested the field of neuroimaging to better understand the distinct processes of neural activity.

Biofeedback

Biofeedback is an underutilized therapeutic tool that affirms mind-body connectivity while giving recipients and clinicians in–the–moment health related information. This further substantiates the notion that physical health can directly affect mental and emotional aspects and vice versa ( Austad & Gendron, 2018). Although there is some consideration for the mind-body connection and how it affects wellness, many forms of traditional psychotherapy do not enter into the therapeutic process with the body at the forefront ( Austad & Gendron, 2018; Fiskum, 2019).

As self–regulation is deeply rooted in the body and neurophysiology, biofeedback may be a functional approach to physiological regulation. This can elevate awareness of the mind-body connection while providing adaptive tools for self–regulation. Provision of such regulation tools can further self–awareness and improve physical and mental health ( Austad & Gendron, 2018). Measurements of high Heart Rate Variability (HRV), and signals of lower cardiac complexity, can provide data suggestive of an increased capacity for emotion regulation and overall psychological wellbeing ( Fiskum, 2019). HRV biofeedback may have a positive effect on “synchronized blood-flow oscillations … further strengthening the functional connectivity between brain areas” ( Fiskum, 2019, p. 418).

Neurofeedback

King and Parada (2020) suggested using mobile brain/body imaging (MoBI) as a more pragmatic way of measuring neuroscientific activation resulting from an intervention within the creative arts therapies (CATs). Mobile brain/body imaging could be a process through which we gain a greater understanding of the relationship between neuroaesthetics and the CATs, the framework of which adopts the “4E” approach to cognition: embodied, extended, embedded, and enactive ( King & Parada, 2020). Although the authors speak primarily in regard to art therapy, they proposed that research using MoBI with other CATs, such as dance/movement therapy could be beneficial in further understanding the underpinnings of mind-body connection as it relates to active art (or dance) making. The use of MoBI supports examination of the mind, body, behavior connection in a more natural setting of artistic practice; furthermore, the therapeutic processes and active factors of therapy have proven to be difficult to capture and can be explored with MoBI. “Importantly, the brain autonomously and continuously senses the body (i.e. interoception). MoBI, allowing the acquisition of brain/body physiological signals during a natural therapeutic encounter, opens the door for studying interoception in the wild” ( King & Parada, 2020, p. 8367). Furthermore, such research could bring greater awareness to the cognitive processes that inform artistic or aesthetic experiences as they relate to one’s sense of self, agency, and efficacy.

Conclusions

Individuals with schizophrenia face disproportionately high barriers to health and wellness. Discrepancies in health care for this population begin with diagnostics ( Metzl & Roberts, 2014; Oud & Jong, 2017) and extend through the duration of the illness, affecting symptomatology, intra- and interpersonal skills, quality of life, self–efficacy, and overall prognosis ( Kohn et al., 2022; Rössler, 2016; Vancampfort et al., 2017). People of color, particularly Black men, have historically been most affected by diagnostic inequities and biases ( Metzl & Roberts, 2014). Furthermore, people with schizophrenia face high rates of stigmatization, not only by the general population, but also by the health care providers by whom they are seeking services ( Ivanova, 2021; Rössler, 2016). These stigmatizing behaviors, coupled with communication differences that people with schizophrenia may experience, deter people with schizophrenia from seeking and receiving quality health care ( Kohn et al., 2022). Moreover, their propensity towards a dissociative relationship with their bodies and additional bodily dysregulations places this population at a proportionately higher risk for medical illness ( Moore et al., 2015; Oud & Jong, 2017; Tan et al., 2021) resulting in a significantly shorter life span than the general population ( Kohn et al., 2022; Swildens et al., 2016; Tan et al., 2021).

The cyclical nature of physical and mental symptomatology triggering one another indicates that improved mind-body awareness could be a supportive option for people with schizophrenia ( Costantini et al., 2020). Recent research has shown that this population is particularly vulnerable to experience diminished understanding of their mind-body connection ( Kohn et al., 2022; Yao & Thakkar, 2022) and a decrease in interoceptive knowledge ( Ardizzi et al., 2016; Torregrossa et al., 2022; Yao & Thakkar, 2022). This limits the ability to process internal and bodily signals and information that could provide insight around physical health needs. Much of the body–mind connection research focuses on externalization and could benefit from an inside-out perspective initiating interventions from the body and making cognitive connections after participants have a bodily, felt experience. This process would support both physical and mental aspects of care benefitting both general and mental health care, both of which are needed for people with schizophrenia.

Dance/movement therapy is a treatment option that addresses physical, mental, and social aspects of participant wellness ( Bryl & Biondo, 2022). More recently, DMT frameworks have been explored and expanded to be inclusive of embodied, neurophysiological theories. Of note is the inclusion of neurophysiological theories which incorporate concepts of attunement and self–regulation both of which play a significant role in DMT ( Homann, 2010, 2020). Due to the direct relationship between the vagus nerve and interoception ( Homann, 2020), DMT would be an apparent intervention choice. As an active and embodied intervention, the research discussed demonstrates that DMT has the capacity to address multi–layered needs of people with schizophrenia including raising interoceptive awareness. As research has shown, DMT for people with schizophrenia can help participants become activated through movement ( Bryl et al., 2020), improve interpersonal relationships, process and express emotions, improve self–efficacy, and increase mind-body connection ( Biondo et al., 2021; Bryl et al., 2020). Dance/movement therapy is an active intervention in which people experiencing all levels of acuity can participate ( Biondo et al., 2021). Moreover, the nonverbal relationships possible through DMT can allow for increased joining with those who may have communication differences. These components of invitation for people with schizophrenia truly meet each participant where they are in their wellness process and destigmatize the diagnosis, allowing an authentic development of healthy ego, self-efficacy, and relationship ( Biondo et al., 2021; Bryl & Biondo, 2022).

Similarly to DMT, biofeedback is an option for further mind-body integration that provides participants with an active role in their wellness ( Austad & Gendron, 2018). Both treatment interventions provide participants with immediate data regarding the effects the body can have on the mind and vice versa. Additionally, both provide in-the-moment information to provide active skills participants can integrate into their daily lives. Collaborative healthcare teams could provide a more holistic approach to treatment for people with schizophrenia, as this could partner complementary areas of expertise, bridge inter–healthcare provider relationships as well as communication between providers and clients, and expand the healthcare continuum for people who have historically been resistant to seeking treatment and stigmatized when they do. Furthermore, applications such as MoBI can expand our current knowledge regarding if and how interoception can positively impact people with schizophrenia and inform future treatment implications ( King & Parada, 2020).

This review seeks to highlight the disparities people with schizophrenia face regarding lack of accessible ( Swildens et al., 2016) and quality health care ( Moore et al., 2015; Sølvhøj et al., 2021), multifaceted forms of stigmatization they encounter ( Ivanova, 2021; Kohn et al., 2022; Sølvhøj et al., 2021), and specific barriers they face regarding the bodily disruptions and dysregulations associated with their symptomatology ( Biondo et al., 2021; Costantini et al., 2020; Torregrossa et al., 2022). Dance/movement therapy is an intervention that can provide individuals diagnosed with schizophrenia an opportunity to participate in an embodied psychosocial treatment intervention that addresses these precise body-based needs, while simultaneously providing physical activation, emotional processing, mind-body connection, interpersonal relationships, and self–regulation. These are components that not only support increased personal and interpersonal wellness, but also provide self–efficacy to encourage physical and mental health care adherence, and embodied treatment experiences placing mind-body wellness at the forefront of care ( Biondo et al., 2021). The addition of biofeedback to DMT could provide further physiological ( Austad & Gendron, 2018; Fiskum, 2019) and neurological data ( King & Parada, 2020). A treatment protocol inclusive of DMT can provide a foundation for the rehumanization process that people with schizophrenia certainly deserve.

Funding Statement

This project was supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) (T3242018). The contents are those of the author and do not necessarily represent the official views of, nor an endorsement, by HRSA, HHS or the U.S. Government. Publication was made possible by support from the Thomas Jefferson University Open Access Fund.

The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

[version 1; peer review: 2 approved with reservations]

Data availability

No data are associated with this article.

References

  1. American Psychiatric Association: Diagnostic and statistical manual of mental disorders: DSM–5. American Psychiatric Association;2013. [Google Scholar]
  2. Ardizzi M, Ambrosecchia M, Buratta L, et al. : Interoception and positive symptoms in schizophrenia. Front. Hum. Neurosci. 2016;10:379. 10.3389/fnhum.2016.00379 [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Austad CS, Gendron MS: Biofeedback: Using the power of mind–body connection, technology, and business in psychotherapies of the future. Prof. Psychol. Res. Pract. 2018;49(4):264–273. 10.1037/pro0000197 [DOI] [Google Scholar]
  4. Behere RV, Thirthalli J, Varambally SS, et al. : Mind–body practices in schizophrenia—Opportunities and challenges. Schizophr. Res. 2019;212:4–5. 10.1016/j.schres.2019.08.018 [DOI] [PubMed] [Google Scholar]
  5. Benson TL, Brugger P, Park S: Body self–disturbance in schizophrenia–spectrum populations: Introducing the Benson et al. Body Disturbances Inventory (B–BODI). PsyCh J. 2019;8:110–121. 10.1002/pchj.280 [DOI] [PubMed] [Google Scholar]
  6. Biondo J, Gerber N, Bradt J, et al. : Single–session dance/movement therapy for thought and behavioral dysfunction associated with schizophrenia: A mixed methods feasibility study. J. Nerv. Ment. Dis. 2021;209(2):114–122. 10.1097/NMD.0000000000001263 [DOI] [PubMed] [Google Scholar]
  7. Bryl K, Biondo J: Dance/movement therapy and schizophrenia spectrum disorders: A reflection of clinical practices and history. OBM Integr. Compliment. Med. 2022;6(4). 10.21926/obm.icm.2104052 [DOI] [Google Scholar]
  8. Bryl K, Bradt J, Cechnicki A, et al. : The role of dance/movement therapy in the treatment of negative symptoms in schizophrenia: A mixed methods pilot study. J. Ment. Health. 2020;13(1):1–11. 10.1080/09638237.2020.1757051 [DOI] [PubMed] [Google Scholar]
  9. Costantini M, Salone A, Martinotti G, et al. : Body representations and basic symptoms in schizophrenia. Schizophr. Res. 2020;222:267–273. 10.1016/j.schres.2020.05.038 [DOI] [PubMed] [Google Scholar]
  10. Davis M: 2018 Guide to the Movement Psychodiagnostic Inventory (MPI). 2019. Reference Source
  11. Fiskum C: Psychotherapy beyond all the words: Dyadic expansion, vagal regulation, and biofeedback in psychotherapy. J. Psychother. Integr. 2019;29(4):412–425. 10.1037/int0000174 [DOI] [Google Scholar]
  12. Gökcen A, Ekici G, Abaoglu H, et al. : The healing effect of goal–oriented dance and movement therapy in schizophrenia: A rater–blinded randomized controlled trial. Arts Psychother. 2020;71:101702. 10.1016/j.aip.2020.101702 [DOI] [Google Scholar]
  13. Gray AEL: Polyvagal–informed dance/movement therapy for trauma: A global perspective. Am. J. Dance Ther. 2017;39:43–46. 10.1007/s10465-017-9254-4 [DOI] [Google Scholar]
  14. Homann KB: Embodied concepts of neurobiology in dance/movement therapy practice. Am. J. Dance Ther. 2010;32:80–99. 10.1007/s10465-010-9099-6 [DOI] [Google Scholar]
  15. Homann KB: Dynamic equilibrium: Engaging and supporting neurophysiological intelligence through dance/movement therapy. Am. J. Dance Ther. 2020;42:296–310. 10.1007/s10465-020-09337-4 [DOI] [Google Scholar]
  16. Ivanova M: The stigmatization of schizophrenia. The University of Ottawa Journal of Medicine. 2021;11(2):47–51. 10.18192/UOJM.V11i2.6078 [DOI] [Google Scholar]
  17. King JL, Parada FJ: Using mobile brain/body imaging to advance research in arts, health, and related therapeutics. Eur. J. Neurosci. 2020;54:8364–8380. 10.1111/ejn.15313 [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Klaver M, Dijkerman HC: Bodily experience in schizophrenia: Factors underlying a disturbed sense of body ownership. Front. Hum. Neurosci. 2016;10:305. 10.3389/fnhum.2016.00305 [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Koch SC: Arts and health: Active factory and a theory framework of embodied aesthetics. Arts Psychother. 2017;54:85–91. 10.1016/j.aip.2017.02.002 [DOI] [Google Scholar]
  20. Koch S, Riege R, Tisborn K, et al. : Effects of dance movement therapy and dance on health–related psychological outcomes. A meta–analysis update. Front. Psychol. 2019;10(1806):1–28. 10.3389/fpsyg.2019.01806 [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Kohn L, Christiaens W, Detraus J, et al. : Barriers to somatic health care for persons with severe mental illness in Belgium: A qualitative study of patients’ and healthcare professionals’ perspectives. Front. Psych. 2022;12:798530. 10.3389/fpsyt.2021.798530 [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Laursen TM: Causes of premature mortality in schizophrenia: A review of literature published in 2018. Curr. Opin. Psychiatry. 2019;32(5):388–393. 10.1097/YCO.0000000000000530 [DOI] [PubMed] [Google Scholar]
  23. Lincoln SH, Johnson T, Winters A, et al. : Social exclusion and rejection across the psychosis spectrum: A systematic review of empirical research. Schizophr. Res. 2021;228:43–50. 10.1016/j.schres.2020.11.056 [DOI] [PubMed] [Google Scholar]
  24. Metzl JM, Roberts DE: Structural competency meets structural racism: Race, politics, and the structure of medical knowledge. Virtual Mentor. 2014;16(9):674–690. 10.1001/virtualmentor.2014.16.09.spec1-1409 [DOI] [PubMed] [Google Scholar]
  25. Moore S, Shiers D, Daly B, et al. : Promoting physical health for people with schizophrenia by reducing disparities in medical and dental care. Acta Psychiatr. Scand. 2015;132:109–121. 10.1111/acps.12431 [DOI] [PubMed] [Google Scholar]
  26. Oud MJT, Jong BM: Somatic diseases in patients with schizophrenia in general practice: Their prevalence and health care. BMC Family. 2017;10(32). 10.1186/1471-2296-10-32 [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Rössler W: The stigma of mental disorders: A millennia–long history of social exclusion and prejudices. EMBO Rep. 2016;17(9):1250–1253. 10.15252/embr.201643041 [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Sabe M, Sentissi O, Kaiser S: Meditation–based mind–body therapies for negative symptoms of schizophrenia: Systematic review of randomized controlled trials and meta–analysis. Schizophr. Res. 2019;212:15–25. 10.1016/j.schres.2019.07.030 [DOI] [PubMed] [Google Scholar]
  29. Savill M, Orfanos S, Bentall R, et al. : The impact of gender on treatment effectiveness of body psychotherapy for negative symptoms of schizophrenia: A secondary analysis of the NESS trial data. Psychiatry Res. 2017;247:73–78. 10.1016/j.psychres.2016.11.020 [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Sølvhøj ID, Kusier AO, Pederson PV, et al. : Somatic health care professionals’ stigmatization of patients with mental disorder: A scoping review. BMC Psychiatry. 2021;21(443):443. 10.1186/s12888-021-03415-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Swildens W, Termorshuizen F, Ridder A, et al. : Somatic care with a psychotic disorder. Lower somatic health care utilization of patient with a psychotic disorder compared to other patient groups and to controls without a psychiatric diagnosis. Admin. Pol. Ment. Health. 2016;43:650–662. 10.1007/s10488-015-0679-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Tan XW, Lee ES, Toh MPH, et al. : Comparison of mental–physical comorbidity, risk of death and mortality among patients with mental disorders—A retrospective cohort study. J. Psychiatr. Res. 2021;142:48–53. 10.1016/j.jpsychires.2021.07.039 [DOI] [PubMed] [Google Scholar]
  33. Torregrossa LJ, Snodgress MA, Hong SJ, et al. : Anomalous bodily maps of emotions in schizophrenia. Schizophr. Bull. 2022;45(5):1060–1067. 10.1093/schbul/sby179 [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Vaisvaser S: The embodied–enactive–interactive brain: Bridging neuroscience and creative arts therapies. Front. Psychol. 2021;12:634079. 10.3389/fpsyg.2021.634079 [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Vancampfort D, Firth J, Schuch FB, et al. : Sedentary behavior and physical activity levels in people with schizophrenia, bipolar disorder and major depressive disorder: A global systematic review and meta–analysis. World Psychiatry. 2017;16:308–315. 10.1002/wps.20458 [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Vogel JS, Gaag M, Slofstra C, et al. : The effect of mind–body and aerobic exercise on negative symptoms in schizophrenia: A meta–analysis. Psychiatry Res. 2019;279:295–305. 10.1016/j.psychres.2019.03.012 [DOI] [PubMed] [Google Scholar]
  37. Yao B, Thakkar K: Interoception abnormalities in schizophrenia: A review of preliminary evidence and an integration with Bayesian accounts of psychosis. Neurosci. Biobehav. Rev. 2022;132:757–773. 10.1016/j.neubiorev.2021.11.016 [DOI] [PubMed] [Google Scholar]
F1000Res. 2023 Apr 28. doi: 10.5256/f1000research.139878.r169980

Reviewer response for version 1

Hod Orkibi 1

Overall, the article focuses on a timely issue of offering DMT to clients with schizophrenia, which is generally an under-investigated field. 

In the Discussion, address clearly the unique contribution of DMT to this population, and how modality-specific change factors are reasoned to lead to outcome. In other words, based on the literature reviewed, it will be meaningful if you specify your own  theory of change with respect to DMT for this population. 

Also, the polyvagal theory has been criticized in the literature, and this has to be mentioned. 

The abbreviation CATs should appear in the first time the term "creative arts therapies" - it appears under: "Contributing factors". This should be followed by CATs. 

The Conclusion section can be more concise in highlighting the take home message of this review to strengthen the impact of the paper.

Is the review written in accessible language?

Yes

Are all factual statements correct and adequately supported by citations?

Partly

Are the conclusions drawn appropriate in the context of the current research literature?

Yes

Is the topic of the review discussed comprehensively in the context of the current literature?

Yes

Reviewer Expertise:

Psychodrama and drama therapy, arts therapies, community mental health, process and outcome research, systematic reviews.

I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.

F1000Res. 2023 Jan 31. doi: 10.5256/f1000research.139878.r160297

Reviewer response for version 1

Robyn Cruz 1

The scope of this paper is impressive and the arguments for providing care for individuals with schizophrenia that is aligned with care for the whole person continues to be a worthy topic for research and practice. The decades-long focus of pharmacotherapy as the primary treatment for schizophrenia continues to show progress, but the need for other treatment modalities such as dance/movement therapy (DMT) to address social and psychological components of the illness such as trauma are still required. This review will combine comments with a focus on strengthening the content to help achieve the worthy goals of the paper.

Introduction – I am not completely clear about the meaning of the sentence “Through a strengths- and body-based approach, dance/movement therapy (DMT) surpasses traditional verbal communication, establishing inclusion for many forms of preferred communication styles (Biondo et al., 2021).” especially for readers who may not have an understanding of DMT. I think here in the introduction – an introduction to the field of DMT is warranted. The section that is on page 5 (of the pdf version of the article) could be moved to the introduction and I believe it would be very useful in tying together other sections of the paper for the reader new to DMT. The sections on body symptomatology, interoception, and mind-body treatments could be helped by setting the context early on with what DMT is and the fact that it has been used for decades with seriously mentally ill patients as well as others.

Discussion – I feel that there needs to be more research cited, and more diversity of sources for the important discussion of mental health disparities. Currently there is sole dependence on Metzl & Roberts (2014). In addition the mention of the changes in rates of diagnosis over time fails to mention the important fact that diagnostic criteria have changed quite drastically over time as well. To cite myself  (Cruz, 1995, p. 38), “Yet a narrowing of diagnostic criteria for schizophrenia has taken place during the last 50 years, changing the determination of who is diagnosed schizophrenic. The DSM-III (1980) represented the sharpest break with previous editions in the definition and diagnostic criteria for schizophrenia (Andreasen & Flaum, 1991). Many forms of the disorder were removed and included in other categories, most notably psychosis not elsewhere classified, affective disorders, and related personality disorders. In spite of this narrowing, research on movement disorders has not regularly included the removed disorders.”

In 1952 DMS I was published and the criteria for schizophrenia as noted above included other disorders that later were winnowed out. DSM II was published in 1968 and DSM III in 1980 – in spite of these changes, it would be good to note if disparities in diagnosis by race continued across the changing symptom criteria.

Also the discussion on stigmatization – other sources should be cited as there is dependence on Rossler (2016). It could be helpful also to make a connection between the discussion on stigmatization and stigmatizing behaviors – it is possible combining the paragraph that begins “Stigmatization also affects people with schizophrenia on personal and social levels.” with the section located under the heading “physical health disparities” could be helpful for the reader.

Think about the sections in “Mental Health Disparities” and “Physical Health Disparities” as setting up the reader for better understanding of why DMT has the potential to promote wellness for this group. I think it is necessary to distinguish better between “Body symptomatology” and “Bodily disturbances…” as what is described under body symptomatology are abnormal involuntary movements which can be naturally occurring or side effects of pharmacology but are related to dysfunction of neurotransmitters of the extrapyramidal system (Cruz, 1995; 2009). I also think that the text in the “Bodily disturbances section could more meaningfully be combined with the “Interoception” section of the paper – they cross-over in ways that might be confusing to the reader not familiar with these terms.

I am curious what the real purpose of the  “Mind-body treatments” section is and if the author thinks of DMT as a mind-body treatment? If so this needs to be clarified for the reader so that the DMT research section (which is brief and does not include any meta-analyses that have been conducted) is clear and then clearly separated from the theoretical sections that follow. These theoretical areas “embodied aesthetics framework and embodied neurology need better framing as theoretical frameworks. How those frameworks might directly impact work with schizophrenic patients needs more obvious connection for the reader.

I am also curious about the inclusion of biofeedback which is a bonafide technique and neurofeedback with seems to be theoretical – what could be learned or achieved with it? They don’t seem to “fit” very well with this paper.

Conclusion – may serve as a good guide for the reorganizing that I’ve suggested in this review. It is comprehensive of the major points in a very clear manner that serves the paper well.

Is the review written in accessible language?

Yes

Are all factual statements correct and adequately supported by citations?

Partly

Are the conclusions drawn appropriate in the context of the current research literature?

Yes

Is the topic of the review discussed comprehensively in the context of the current literature?

Yes

Reviewer Expertise:

Dance/movement therapy, movement disorders, research methods

I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.

References

  • 1. : An empirical investigation of the Movement Psychodiagnostic Inventory. The University of Arizona, Tucson .1995; Reference source
  • 2. : Validity of the Movement Psychodiagnostic Inventory: A Pilot Study. American Journal of Dance Therapy .2009;31(2) : 10.1007/s10465-009-9072-4 122-135 10.1007/s10465-009-9072-4 [DOI] [Google Scholar]

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Data Availability Statement

    No data are associated with this article.


    Articles from F1000Research are provided here courtesy of F1000 Research Ltd

    RESOURCES